Education
About Us
Working with TipRanks
Follow Us
InMode (INMD)
NASDAQ:INMD
INMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.14 - $19.85
Previous CloseN/A
Volume968.14K
Average Volume (3M)908.90K
Market Cap
$1.04B
Enterprise Value$414.34M
Total Cash (Recent Filing)$510.68M
Total Debt (Recent Filing)$6.10M
Price to Earnings (P/E)6.0
Beta1.27
Next Earnings
Oct 22, 2025EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding69,558,670
10 Day Avg. Volume726,569
30 Day Avg. Volume908,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue1.03
Enterprise Value/Gross Profit1.29
Enterprise Value/Ebitda3.36
Forecast
1Y Price Target
$17.50Price Target Upside17.45% Upside
Rating ConsensusHold
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Product DemandA shift toward noninvasive platforms highlights increasing demand for lower-cost procedures, positioning INMD well to capture evolving consumer preferences.
Product OfferingThe strong traction seen with the CO2 laser and consideration of further laser procedures strengthens INMD's ability to be a one-stop-shop for providers.
Bears Say
Economic OutlookAnalyst maintains a Hold rating given the uncertain economic outlook.
Market ConditionsWeakness in its more profitable US business is causing a US/OUS mix shift, with hopes that an eventual US rebound would benefit its bottom line.
Revenue GuidanceThe company lowered its FY25 revenue guidance to $365M-$375M from $395M-$405M.
InMode News
INMD FAQ
What was InMode’s price range in the past 12 months?
InMode lowest stock price was $13.14 and its highest was $19.85 in the past 12 months.
What is InMode’s market cap?
InMode’s market cap is $1.04B.
When is InMode’s upcoming earnings report date?
InMode’s upcoming earnings report date is Oct 22, 2025 which is in 24 days.
How were InMode’s earnings last quarter?
InMode released its earnings results on Jul 30, 2025. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.411 by $0.059.
Is InMode overvalued?
According to Wall Street analysts InMode’s price is currently Undervalued.
Does InMode pay dividends?
InMode does not currently pay dividends.
What is InMode’s EPS estimate?
InMode’s EPS estimate is 0.34.
How many shares outstanding does InMode have?
InMode has 69,558,670 shares outstanding.
What happened to InMode’s price movement after its last earnings report?
InMode reported an EPS of $0.47 in its last earnings report, beating expectations of $0.411. Following the earnings report the stock price went down -2.865%.
Which hedge fund is a major shareholder of InMode?
Currently, no hedge funds are holding shares in INMD
InMode Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.50 (17.45% Upside)
$17.50 (17.45% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.32%
12-Months-Change
Fundamentals
Return on Equity
25.91%
Trailing 12-Months
Asset Growth
-17.62%
Trailing 12-Months
Company Description
InMode
InMode Ltd. is a global provider of innovative and minimally invasive aesthetic and medical technologies. The company specializes in devices that utilize radiofrequency (RF) technology to perform various aesthetic procedures, including body contouring, facial rejuvenation, and hair removal. InMode operates primarily in the aesthetic medicine sector, offering a range of products designed for plastic surgeons, dermatologists, and other medical professionals. Its core products include the BodyTite, FaceTite, and Morpheus8 platforms, which enhance both surgical and non-surgical treatment options for patients seeking cosmetic improvements.
INMD Company Deck
INMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted revenue growth, strong gross margins, and strategic market expansions. However, challenges in the North American market, reduced guidance, and increased operating expenses were noted as significant concerns.View all INMD earnings summariesINMD Stock 12 Month Forecast
Average Price Target
$17.50
▲(17.45% Upside)
Technical Analysis
Orthofix
―
AxoGen
―
Establishment Labs Holdings
―
SS Innovations International
―
Bioventus
―
Ownership Overview
―
Insiders
8.41% Mutual Funds
25.16% Other Institutional Investors
63.95% Public Companies and Individual Investors